(Q48758554)

15 February 2018

title

Development of autoimmune hepatitis following liver transplantation for primary biliary cirrhosis. (English)

1 reference

15 February 2018

primary biliary cholangitis

main subject

liver cirrhosis

0 references

liver transplantation

1 reference

1 reference

0 references

author

Alastair Burt

4

1 reference

15 February 2018

author name string

Jones DE

1

1 reference

15 February 2018

James OF

2

1 reference

15 February 2018

Portmann B

3

1 reference

15 February 2018

Williams R

5

1 reference

15 February 2018

Hudson M

6

1 reference

15 February 2018

language of work or name

English

0 references

publication date

1 July 1999

1 reference

15 February 2018

published in

Hepatology

1 reference

15 February 2018

volume

30

1 reference

15 February 2018

issue

1

1 reference

15 February 2018

page(s)

53-57

1 reference

15 February 2018

Primary biliary cirrhosis

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300103

7 January 2021

Transplantation for primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300103

7 January 2021

Efficacy of liver transplantation in patients with primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300103

7 January 2021

Referral of patients with primary biliary cirrhosis for liver transplantation.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300103

7 January 2021

Recurrence of primary biliary cirrhosis after liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300103

7 January 2021

Recurrence of primary biliary cirrhosis after liver transplantation following FK506-based immunosuppression

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300103

7 January 2021

Primary biliary cirrhosis. Histological evidence of disease recurrence after liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300103

7 January 2021

Histological evidence for recurrence of primary biliary cirrhosis after liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300103

7 January 2021

Structural integrity and identification of causes of liver allograft dysfunction occurring more than 5 years after transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300103

7 January 2021

Kinetics of anti-M2 antibodies after liver transplantation for primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300103

7 January 2021

Recurrence of primary biliary cirrhosis in the liver allograft: the effect of immunosuppression

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300103

7 January 2021

Graft and systemic disease in long-term survivors of liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300103

7 January 2021

Meeting report: International Autoimmune Hepatitis Group

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300103

7 January 2021

The variant forms of autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300103

7 January 2021

Recurrence of autoimmune chronic active hepatitis following orthotopic liver grafting

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300103

7 January 2021

Disease recurrence and rejection following liver transplantation for autoimmune chronic active liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300103

7 January 2021

Liver transplantation for autoimmune hepatitis: a 12-year experience

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300103

7 January 2021

Hepatocellular carcinoma in primary biliary cirrhosis and its impact on outcomes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300103

7 January 2021

De-novo autoimmune hepatitis after liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300103

7 January 2021

Weaning of immunosuppression in liver transplant recipients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300103

7 January 2021

Raised levels of antibodies to human viruses at the clinical onset of autoimmune chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300103

7 January 2021

Epstein-Barr virus as a trigger for autoimmune hepatitis in susceptible individuals

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300103

7 January 2021

The basis of autoimmunity: Part II. Genetic predisposition

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300103

7 January 2021

Genetic analysis of autoimmune disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300103

7 January 2021

Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300103

7 January 2021

Genetic predispositions for the immunological features of chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510300103

7 January 2021

Identifiers

DOI

10.1002/HEP.510300103

1 reference

15 February 2018

release_nm5s476ddzdhpdt2t4lpy666zq

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/nm5s476ddzdhpdt2t4lpy666zq

24 November 2022

mapped directly with Wikidata item

PubMed ID

10385638

1 reference

15 February 2018